RHC 80267

• 产品号: R2028
• CAS号: 83654-05-1
• 分子式: C20H34N4O4
• 分子量: 394.50836
• 纯 度: ≥98% (HPLC)

产品别名

• 标题: RHC 80267
• IUPAC标准名: cyclohexylideneamino N-[6-({[(cyclohexylideneamino)oxy]carbonyl}amino)hexyl]carbamate
• IUPAC传统名: cyclohexylideneamino N-[6-({[(cyclohexylideneamino)oxy]carbonyl}amino)hexyl]carbamate
• 别名: U 57908; 1,6-bis(Cyclohexyloximinocarbonylamino)hexane

产品登记号

• MDL号: MFCD00210844
• CAS号: 83654-05-1

产品性质

• Empirical Formula (Hill Notation): C20H34N4O4
• 纯度: ≥98% (HPLC)
• 外观: white solid
• 溶解度: DMSO: soluble9 mg/mL
• 个人保护装置: Eyeshields, Gloves, type N95 (US), type P1 (EN143) respirator filter
• 德国WGK号: 3

产品详细信息

详细说明 (简体中文)

Biochem/physiol Actions
RHC 80267 is a diacylglycerol (DAG) lipase inhibitor and an important second messenger in signal transduction pathways. RHC 80267 is generated by the hydrolysis of phosphatidylinositol (PI) and bPC by phospholipase C (PLC). DAG mediates the actions of a large number of hormones and cytokines by activating protein kinase C (PKC). A sustained elevation in intracellular DAG may cause neoplastic transformation.

详细说明 (English)

Biochem/physiol Actions
RHC 80267 is a diacylglycerol (DAG) lipase inhibitor and an important second messenger in signal transduction pathways. RHC 80267 is generated by the hydrolysis of phosphatidylinositol (PI) and bPC by phospholipase C (PLC). DAG mediates the actions of a large number of hormones and cytokines by activating protein kinase C (PKC). A sustained elevation in intracellular DAG may cause neoplastic transformation.